Literature DB >> 1086057

Idiopathic portal hypertension.

J P Villeneuve, P M Huet, J G Joly, D Marleau, J Côté, A Légaré, M Lafortune, P Lavoie, A Viallet.   

Abstract

Idiopathic portal hypertension is reported in five cases including one case of chronic arsenical intake and one case of chronic industrial vinyl chloride exposure. In all five cases the patients presented with gastrointestinal bleeding as the chief complaint. Physical examination was within normal limits except for splenomegaly in all. Results of liver function tests were normal, except for the relative clearance of sulfobromophtalein. A surgical liver biopsy specimen was obtained in all cases and showed moderate degrees of portal fibrosis, but no cirrhosis. Combined umbilicoportal, hepatic vein and superior mesenteric artery catheterization was performed in all cases. Hepatoportographies showed distortion of the intrahepatic portal venous system and cut-off of small portal venules. Porto-hepatic gradients ranged from 14.0 to 20.5 mm Hg. The portal hypertension was both sinusoidal and presinusoidal in nature but mainly presinusoidal. Hepatic extraction of indocyanine green and of albumin microaggregates was normal, thereby suggesting normal functional portal blood supply to the liver. The patients with arsenical or vinyl chloride exposure could not be differentiated from the other three patients with idiopathic portal hypertension. These results suggest that idiopathic portal hypertension may be related to domestic or industrial exposure to other hepatotoxins.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1086057     DOI: 10.1016/0002-9343(76)90323-5

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  15 in total

1.  Implications of portal vein thrombosis after splenectomy for patients with idiopathic portal hypertension.

Authors:  Teijiro Hirashita; Masayuki Ohta; Seiichiro Kai; Takashi Masuda; Hidetoshi Eguchi; Yukio Iwashita; Tadashi Ogawa; Seigo Kitano
Journal:  Surg Today       Date:  2011-10-04       Impact factor: 2.549

Review 2.  Pathophysiology and epidemiology of portal hypertension.

Authors:  H Okumura; T Aramaki; Y Katsuta
Journal:  Drugs       Date:  1989       Impact factor: 9.546

3.  Idiopathic portal hypertension associated with cytotoxic drugs.

Authors:  P Shepherd; D J Harrison
Journal:  J Clin Pathol       Date:  1990-03       Impact factor: 3.411

4.  Idiopathic portal hypertension (perisinusoidal fibrosis) after renal transplantation.

Authors:  C Nataf; G Feldmann; D Lebrec; C Degott; J M Descamps; B Rueff; J P Benhamou
Journal:  Gut       Date:  1979-06       Impact factor: 23.059

5.  Idiopathic portal hypertension in renal transplant recipients: report of two cases.

Authors:  N Yoshimura; T Oka; Y Ohmori; T Yasumura; H Kohnosu; T Kobashi
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

6.  Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment.

Authors:  Shiv Kumar Sarin; Ashish Kumar; Yogesh Kumar Chawla; Sanjay Saran Baijal; Radha Krishna Dhiman; Wasim Jafri; Laurentius A Lesmana; Debendranath Guha Mazumder; Masao Omata; Huma Qureshi; Rizvi Moattar Raza; Peush Sahni; Puja Sakhuja; Mohammad Salih; Amal Santra; Barjesh Chander Sharma; Praveen Sharma; Gamal Shiha; Jose Sollano
Journal:  Hepatol Int       Date:  2007-09-11       Impact factor: 6.047

7.  Elevated levels of circulating angiotensin converting enzyme in patients with hepatoportal sclerosis.

Authors:  Yavuz Beyazit; Mehmet Ibis; Tugrul Purnak; Turan Turhan; Murat Kekilli; Mevlut Kurt; Abdurrahim Sayilir; Ibrahim Koral Onal; Nesrin Turhan; Adnan Tas; Seyfettin Köklü; Ibrahim C Haznedaroglu
Journal:  Dig Dis Sci       Date:  2011-02-03       Impact factor: 3.199

8.  Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients.

Authors:  S Hillaire; E Bonte; M-H Denninger; N Casadevall; J-F Cadranel; D Lebrec; D Valla; C Degott
Journal:  Gut       Date:  2002-08       Impact factor: 23.059

9.  Hyperglobulinemia in alcoholic cirrhosis. Relationship with portal hypertension and intrahepatic portal-systemic shunting as assessed by Kupffer cell uptake.

Authors:  G Pomier-Layrargues; P M Huet; G Richer; D Marleau; A Viallet
Journal:  Dig Dis Sci       Date:  1980-07       Impact factor: 3.199

10.  Intrahepatic portal vein sclerosis in patients without a history of liver disease. An autopsy study.

Authors:  I R Wanless; V Bernier; M Seger
Journal:  Am J Pathol       Date:  1982-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.